The most popular, comprehensive and up-to-date medicine online.
|
|
ED Treatment
Recently Added
Recent News
03/17/10 Nova Century Scientific to market and sell Diamedix’ products in Canada
IVAX Diagnostics, Inc. (AMEX:IVD), a fully integrated global invitro diagnostics company, announced that its subsidiary, Diamedix Corporation, has signed a distribution agreement with Nova Century Scientific (“Nova”), a leading Canadian distributor and manufacturer of diagnostic kits and laboratory supplies. Through this agreement, which marks IVAX Diagnostics’ entry into the Canadian market, Nova will market and sell 50 of Diamedix’s products, including analyzer instrumentation, under the Diamedix brand. Nova distributes products to hospitals, clinical laboratories and research institutions across Canada, and is a subsidiary of IMMCO Diagnostics, Inc. 03/17/10 Access MediQuip enhances Recall Management Service for implantable devices Access MediQuip, LLC, the nation's first and largest provider of outsourced implantable medical device management solutions to the healthcare industry, announced today it has enhanced its proprietary Recall Management Service, "RMS," for its customers nationwide. The new release is designed to protect patients, inform and empower surgeons and facilities, and help payers improve quality while managing cost. 03/17/10 AstraZeneca's CRESTOR: Health Canada approves new indication Approval based on JUPITER trial which demonstrated reduction of cardiovascular events by nearly half Top Category's Bestsellers
Weight LossWeight loss is a reduction of body weight that is triggered by exercise, dieting or an involuntary condition such as an illness. As it is well known when the body does not get enough calories it starts to burn the fat that was deposited in the fat tissue. Normal intake of calories for a human being is about 1800-2200 calories a day. One gram of burned fat produces 9 calories so it is easy to count how much fat are you burning when you lower your calories intake. Dieting or voluntary weight loss nowadays is very common for people with health problems like obesity, heart dysfunction or for people who might not necessarily need it but want to look good. Weight loss or even fast weight loss may be caused by illness that are associated with such severe conditions like:
Obesity is a condition of extreme overweight when the body mass index or BMI is above 30. Or for people with over risk factors as hypertension or diabetes above 27. The weight loss drugs used for fighting obesity is most commonly given only by prescription and should not be used without doctors supravision. Most of the weight loss drugs work by suppressing the appetite only a few like Xenical have different therapeutic action. Category News
04/24/09 - Sorafenib and vitamin K combo shows anti-tumor effects in pancreas cancer, hepatocellular carcinoma
A combination of sorafenib and vitamin K had an effect in vitro on both human pancreas cancer and hepatocellular carcinoma, according to researchers from the Kimmel Cancer Center at Jefferson.
06/21/07 - Study Examines Effects Of Over-The-Counter Strength Orlistat For Weight Loss
The first and only over-the-counter product for weight loss approved by the Food and Drug Administration was available from Friday, June 15.
06/04/07 - Anti-Obesity Drug's Claimed Additional Benefits On 'Cardiometabolic Risk Factors' Questioned
Additional beneficial effects on 'cardiometabolic risk factors' beyond those expected from weight loss in trials of the anti-obesity drug rimonabant may not be due to the drug itself, reports an article in the June issue of Drug and Therapeutics Bulletin
05/23/07 - Low-Glycemic Load Diet May Be More Effective For Dieters With Certain Insulin Response Patterns
Overweight individuals who secrete insulin at a higher level may experience greater weight loss by selecting a low-glycemic load diet, compared to a low-fat diet, according to a study in the May 16 issue of JAMA. The researchers also found a low-glycemic
05/23/07 - New Techniques Redefine Assessment Of Liver Disease
Research presented at Digestive Disease Week 2007 (DDW) introduces unique methods for evaluating patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most common liver disease in the world and the development of novel procedures for defi |
